ClinicalTrials.Veeva

Menu

Treatment of Peri-implant Mucositis by Application of a Spermidine-based Gel

F

Federico II University

Status

Enrolling

Conditions

Mucositis Oral
Peri-implant Mucositis

Treatments

Procedure: Spermidine gel
Procedure: NSMD

Study type

Interventional

Funder types

Other

Identifiers

NCT05926557
249/2023

Details and patient eligibility

About

The aim of the study is to evaluate the potential of a spermidine-based topical gel as an adjuvant to non-surgical treatment of peri-implant mucositis. After a meticulous selection, patients will be randomly assigned to Test (spermidine gel + non-surgical debridement) or Control group (non-surgical debridement).

Full description

Following the recording of the clinical parameters (BoP, FMPS, FMBS, PD), mechanical therapy (NSMD) will be performed in the Test group (spermidine gel) by means of an ultrasonic scaler with a plastic tip. Finally, the spermidine-based gel will be applied in the peri-implant sulcus using a blunt-tipped needle. Control group will instead be treated only through the NSMD.

Finally, after 3 months the clinical parameters (BoP, FMPS, FMBS, PD) will be recorded again and the final evaluation will be performed. Data analysis will be performed using statistical software.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years;
  • Non-smokers and smokers ( ≤ 10 cigarettes/day);
  • Presence of at least 1 implant in mucositis, clinically and radiographically detected;
  • The implant in mucositis (tissue-level or bone-level) must support a fixed prosthetic device (single crown), cemented or screwed.

Exclusion criteria

  • Cancer patients;
  • Periodontally Compromised Patients;
  • Uncontrolled diabetic patients;
  • Prolonged antibiotic treatment or anti-inflammatory treatment in the previous 6 months;
  • Pregnant or breastfeeding patients;
  • Implants that support mobile prosthetic products;
  • Implants in peri-implantitis, detected clinically and radiographically.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

20 participants in 2 patient groups

Spermidine Group
Experimental group
Description:
Mechanical therapy (NSMD) will be performed by means of an ultrasonic scaler with a plastic tip. Finally, the spermidine-based gel will be applied in the peri-implant sulcus using a blunt-tipped needle.
Treatment:
Procedure: Spermidine gel
NSMD Group
Active Comparator group
Description:
Control group will be treated only through a non-surgical mechanical therapy with curettes or scaler peek tips.
Treatment:
Procedure: NSMD

Trial contacts and locations

1

Loading...

Central trial contact

Luca Ramaglia

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems